Physiologic and Pathologic Drug Resistance in Ovarian Carcinoma: A Hypothesis Based on a Clonal Progression Model

Author： Pusztai Lajos Siddik Zahid H. Mills Gordon B. Bast Robert C.

ISSN： 0284-186X

Source： Acta Oncologica, Vol.37, Iss.7-8, 1998-12, pp. : 629-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview

By Kerbel R.S.

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin Wang Li Beretov Julia Hao Jingli Xiao Weiwei Li Yong

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite

Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?

By Bredel M. Bredel C. Sikic B.I.

Lancet Oncology, Vol. 5, Iss. 2, 2004-02 ,pp. : 89-100

Elsevier

Access to resources Recommend Favorite

Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 639-651

Spandidos Publications

Access to resources Recommend Favorite

Factors Predictive of Survival after First Relapse or Progression in Advanced Epithelial Ovarian Carcinoma: A Prediction Tree Analysis-Derived Model with Test and Validation Groups

By Hoskins P. Tu D. James K. Pater J. Koski B.

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 224-230

Elsevier

Access to resources Recommend Favorite